Zydus Lifesciences bags Doxepin Tablets FDA approval for insomnia

Pallavi Madhiraju- August 17, 2023 0

Zydus Lifesciences Limited has secured a pivotal nod from the United States Food and Drug Administration (USFDA) for its Doxepin Tablets, available in 3 mg ... Read More

Glenmark Pharmaceuticals gets FDA approval for generic Protopic Ointment

Pallavi Madhiraju- August 17, 2023 0

Glenmark Pharmaceuticals Ltd., a global leader in pharmaceutical research, has secured the final nod from the U.S. Food & Drug Administration (U.S. FDA) for its ... Read More

FDA greenlights Pfizer’s ELREXFIO for advanced multiple myeloma treatment

Pallavi Madhiraju- August 17, 2023 0

Pfizer Inc. has earned accelerated approval from the U.S. Food and Drug Administration (FDA) for its innovative drug, ELREXFIO (elranatamab-bcmm). This drug aims to treat ... Read More

Aurobindo Pharma’s subsidiary Eugia Pharma gets FDA approval for Icatibant Injection

Pallavi Madhiraju- August 16, 2023 0

In a pivotal move bolstering its footprint in the global pharmaceutical landscape, Aurobindo Pharma Limited's subsidiary, Eugia Pharma Specialities Limited, has achieved final authorization from ... Read More

Lupin gains FDA approval for generic Toprol-XL Tablets

Pallavi Madhiraju- August 16, 2023 0

Lupin Limited, a dominant player in the global pharmaceutical landscape, announced its triumph in obtaining the coveted approval from the United States Food and Drug ... Read More

Dr. Reddy’s Laboratories debuts generic version of KOMBIGLYZE XR in US

Pallavi Madhiraju- August 13, 2023 0

In a significant development for diabetes treatment in the U.S., Dr. Reddy's Laboratories has unveiled its Saxagliptin and Metformin Hydrochloride Extended-Release Tablets. This launch introduces ... Read More

Lupin subsidiary gets FDA approval for Fluocinolone Acetonide Oil

Pallavi Madhiraju- August 9, 2023 0

Lupin Limited said that their wholly-owned US subsidiary, Novel Laboratories Inc., has secured approval from the US Food and Drug Administration (US FDA) for its ... Read More

Sage Therapeutics, Biogen get ZURZUVAE FDA approval for postpartum depression treatment

Pallavi Madhiraju- August 5, 2023 0

Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAE (zuranolone) 50 mg for adults ... Read More

Balfaxar receives FDA nod for treating acquired coagulation factor deficiency

Pallavi Madhiraju- July 26, 2023 0

Octapharma USA has announced the US Food and Drug Administration (FDA)'s approval of Balfaxar (prothrombin complex concentrate, human-lans), a treatment for urgent reversal of acquired ... Read More

Aurobindo Pharma subsidiary receives FDA approval for Plerixafor Injection

Pallavi Madhiraju- July 25, 2023 0

Eugia Pharma Specialities Limited, a fully-owned subsidiary of India-based Aurobindo Pharma Limited, has received final approval from the US Food and Drug Administration (FDA). This ... Read More